- Petronas Chemicals reported their earnings for the second quarter of 2024.
- The Earnings Per Share (EPS) was 10 sen, surpassing the estimated 9 sen.
- The net income for the quarter was 777.0 million ringgit.
- Total revenue reported was 7.73 billion ringgit.
- Analyst recommendations include 1 buy, 8 holds, and 10 sells.
A look at Petronas Chemicals Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores analysis, Petronas Chemicals Group Bhd. shows a moderate outlook for its overall performance. With balanced scores of 3 in Value, Dividend, and Growth factors, the company seems to be positioned averagely in terms of its financial health and potential for growth. However, it excels in Resilience with a score of 4, indicating its ability to weather market challenges effectively. This aspect suggests that Petronas Chemicals Group is well-equipped to handle economic uncertainties and disruptions.
On the downside, the company’s Momentum score is rated at 2, indicating a relatively weaker performance in terms of market momentum and investor sentiment. Despite this, Petronas Chemicals Group Bhd. remains a strong player in the chemical industry, offering a diversified portfolio of petrochemical products that cater to various sectors. With a focus on olefins, polymers, fertilisers, methanol, and other basic chemicals and derivative products, the company continues to play a significant role in the market while striving for steady growth and resilience.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
